In a deal that Noetik’s leaders call a new paradigm for AI-focused biotech, GSK is paying millions to license AI models rather than drug candidates.
The British pharma giant is ...
Noetik, an AI-native biotech company pioneering self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therapeutics, announced today a five-year strategic collaboration and AI model licensing agreement ...
Cartography Biosciences, a precision medicine company creating therapeutics guided by the first-ever comprehensive antigen atlas for immuno-oncology targets, launched today with $57 million in initial funding. 8VC led the ...
The powerful gene-editing technique known as CRISPR has raised a lot of hope in recent years for its potential to offer new ways to treat many diseases, including cancer. But until ...
